News | November 18, 2009

New Study Finds Cardiac CT Scans Improve Survival

November 18, 2009 – Utilizing newer cardiac computed tomography (CT) machines to find plaque and blockages in the coronary arteries led to better survival among those undergoing the test, according to a study presented Sunday at the American Heart Association Meeting in Orlando, Fla.

Society of Cardiovascular Computed Tomography (SCCT) president-elect, Matthew J. Budoff, M.D., is the study’s lead author and a researcher at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). Dr. Budoff said previous studies had found assessing heart disease using CT heart scans could predict overall death risks in most American adults, but did not look at whether the knowledge gained by undergoing the test led to better outcomes.

In the study of 4,224 patients, 60 percent underwent the CT angiography (CTA) and 40 percent did not. Both groups were followed for almost seven years, and then all-cause mortality was assessed. Cardiac patients who did not undergo CTA were almost four-fold more likely to die during follow-up.

“This study indicates that cardiac CT scans can provide patients and physicians an earlier and more accurate evaluation of their coronary arteries than traditional tests,” said Dr. Budoff. “The advanced knowledge clearly allows more aggressive and better treatments to be provided. Previous studies found cardiac CT scans encourage compliance with medications and lifestyles that are protective for coronary health, and to be more accurate than stress tests. This new, large study now shows that outcomes are improved with this knowledge.”

In total, 270 deaths were recorded over 80 months of follow-up. The death rate was significantly lower in the group undergoing the CT angiogram (n=86) as compared to the standard of care group (n=184).

“This study provides significant validation of cardiac CT scans,” said Dr. Budoff. “Improved compliance with therapies, more accurate assessment of risk, and identification of coronary stenosis provide important information in assessing a patient’s overall death risk. With this information, physicians can advise patients on diet, medications, exercise and other lifestyle changes that will help them avoid the risk of heart attack, strokes and other health problems.”

“This is a most important study conducted by Dr. Budoff and echoes the sentiment of the SCCT, which espouses that cardiac CT angiography is the most accurate and noninvasive diagnostic imaging test for the detection of coronary artery disease,” said Dr. Jack Ziffer, Ph.D., M.D., FSCCT chief of radiology at Baptist Hospital and SCCT president.

For more information: www.SCCT.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init